The Multilevel CerviKit includes a complete suite of implants and single-use instruments. Credit: Xenco Medical / Business Wire.

Xenco Medical has announced receipt of approval from the US Food and Drug Administration (FDA) for the launch of its single-use Multilevel CerviKit.

With the latest launch, the company has expanded its portfolio of ambulatory surgery centre (ASC) surgical devices.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

The Multilevel CerviKit includes a complete suite of implants and single-use instruments for two, three and four-level anterior cervical spine procedures.

It has been optimised for ASC settings.

The Multilevel CerviKit has been developed based on the company’s existing disposable spinal implant and instrument platforms portfolio, which is included in its ASC CerviKit.

Its cervical plating options feature an intuitive locking mechanism, dual-textured surface for thorough fixation and optimally thin profile.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Furthermore, the sterile-packaged system has been developed to improve intraoperative efficiency.

The device is developed to strengthen the capabilities of ASCs, allowing them to overcome sterilisation hurdles while providing optimal care.

Xenco Medical founder and CEO Jason Haider said: “As Covid-19 spurred increased demand for sterile-packaged, single-use spinal platforms and accelerated growth in the volume of outpatient cervical spine procedures, we have bolstered our commitment to expanding access to safer, streamlined surgical procedures through the launch of our single-use Multilevel CerviKit.”

The company stated that its spinal system is designed for logistical efficiency and surgical performance.

Easily transportable, the disposable spinal implant systems are optimally calibrated and sterile-packaged for individual use.

The single-use implant systems of the company are also compatible with its intelligent surgical vending machines and can be trained for use on a glasses-free holographic surgical simulation platform.